Duration of the P wave and P wave dispersion in subclinical hyperthyroidism

Endocrine Practice

Volumn 9, Issue 3, 2003, Pages 200-203

  Çetinarslan, Berrin ^a   Akkoyun, Mustafa ^a   Cantürk, Zeynep ^a   Tarkun, Ilhan ^a   Kahranman, Göksel ^a   Komsuoglu, Baki ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BLOOD; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; MALE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 2342571055     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.9.3.200     Document Type: Article

References (22)

1. Tajtakova M, Langer P, Semanova Z, Tomklova Z. Contribution of thyroid gland ultrasound for screening of patients with suspected subclinical thyroid gland disorders. Bratisl Lek Listy. 1999;100:196-199.
2. Rodbard HW, Gharib H, Garcia M, Baskin HJ, Feld S, Cobin RH. AACE commentary on subclinical hyperthyroidism. Endocr Pract. 1999;5:220-221.
3. Biondi B, Fazio S, Cuocolo A, et al. Impaired cardiac reserve and exercise capacity in patients receiving longterm thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab. 1996;81:4224-4228.
4. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249-1252.
5. Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998;135(5 Pt 1):733-738.
6. Gialafos JE, Dilaveris PE, Gialafos EJ, Andrikopoulos GK, Richter DJ, Triposkiadis F. P-wave dispersion: a valuable electrocardiographic marker for the prediction of paroxysmal lone atrial fibrillation. Ann Noninvasive Electrocardiol. 1999;4:39-45.
7. Yamada T, Fukunami M, Shimonagata T, et al. Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation. Eur Heart J. 1999;20:211-220.
8. Dilaveris PE, Gialafos EJ, Chrissos D, et al. Detection of hypertensive patients at risk for paroxysmal atrial fibrillation during sinus rhythm by computer-assisted P wave analysis. J Hypertens. 1999;17:1463-1470.
9. Koutras DA. Subclinical hyperthyroidism. Thyroid. 1999;9:311-315.
10. Surks MI, Ocampo E. Subclinical thyroid disease. Am J Med. 1996;100:217-223.
11. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid. 1998;8:803-813.
12. Biondi B, Fazio S, Carella C, et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab. 1993;77:334-338.
13. Brucker-Davis F, Skarulis MC, Grace MB, et al. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone: the National Institutes of Health Prospective Study. Ann Intern Med. 1995;123:572-583.
14. Kahaly GJ, Matthews CH, Mohr-Kahaly S, Richards CA, Chatterjee VK. Cardiac involvement in thyroid hormone resistance. J Clin Endocrinol Metab. 2002;87:204-212.
15. Prystowsky EN, Katz A. Atrial fibrillation. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. Philadelphia: Lippincott-Raven, 1998: 1661-1693.
16. Montereggi A, Marconi P, Olivotto I, et al. Signal-averaged P-wave duration and risk of paroxysmal atrial fibrillation in hyperthyroidism. Am J Cardiol. 1996;77:266-269.
17. Johnson PN, Freedberg AS, Marshall JM. Action of thyroid hormone on the transmembrane potentials from sinoatrial node cells and atrial muscle cells in isolated atria of rabbits. Cardiology. 1973;58:273-289.
18. Abe A, Yamamoto T, Isome M, et al. Thyroid hormone regulates expression of shaker-related potassium channel mRNA in rat heart. Biochem Biophys Res Commun. 1998;245:226-230.
19. Williams LT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch HR Jr. Thyroid hormone regulation of betaadrenergic receptor number. J Biol Chem. 1977;252:2787-2789.
20. Pachucki J, Burmeister LA, Larsen PR. Thyroid hormone regulates hyperpolarization-activated cyclic nucleotide-gated channel (HCN2) mRNA in the rat heart. Circ Res. 1999;85:498-503.
21. Cheema AN, Ahmed MW, Kadish AH, Goldberger JJ. Effects of autonomic stimulation and blockade on signalaveraged P wave duration. J Am Coll Cardiol. 1995;26:497-502.
22. Aytemir K, Hnatkova K, Malik M. Duration of the P wave and P wave dispersion in normal healthy population. Turkish J Interven Cardiol. 1999;3:142-147.